Investment Firms in South San Francisco, California, United States
Known historically as "The Birthplace of Biotechnology," its legacy in life sciences continues to define its core venture capital identity. The ecosystem has since diversified, with notable activity in fintech and enterprise software, supported by a concentration of specialized investment firms. Its proximity to both San Francisco and major research institutions fosters a distinct, industry-focused investment environment.
South San Francisco, California, United States's investment landscape is shaped by Biotech & Life Sciences, with 67% of its 3 investment firms focused on this sector. The most active by portfolio size are Stripe, Ono Venture Investment, and Verily.
Biotech & Life Sciences dominates the investment landscape in South San Francisco, with 67% of investment firms focused on this sector.
Last updated: 20 October 2026
Investment Firms
3
Total Investments
100
Top Sector
Biotech & Life Sciences
Top Stage
Seed
Top Investment Sectors in South San Francisco
The most popular sector focus among South San Francisco investment firms is Biotech & Life Sciences, with 2 investment firms (67%) investing in the space. This is followed by Healthcare (2), Fintech (1), Developer Tools (1), SaaS (1).
Investment Stages in South San Francisco
South San Francisco investment firms are most active at the Seed stage (3 investment firms). This is followed by Series A (3), Series C (2), Series B (2), Series F (1).
Stripe
South San Francisco, California, United States
78 investments
Seed, Series A
Fintech, Developer Tools, SaaS …
Ono Venture Investment
South San Francisco, California, United States
13 investments
Series B, Series A
Biotech & Life Sciences, Healthcare
Verily
South San Francisco, California, United States
9 investments
Series C, Series A
Biotech & Life Sciences, Healthcare